Moreover, in PD serum samples, lower levels of metabolic modulator Fibroblast growth factor 21 (FGF21) and IL-9 were found, together with a higher concentration of proinflammatory factors (CRP, TNF-α, chemokine macrophage inflammatory proteins (MIPs)) [163]. This evidence concerns the gene FGF21 and Parkinson disease.